1Connor KM,Pavidsm SRT.The neurobiology of generalized anxiety disorder[J].Buil Psychiatry,1998,44:1284-1287.
2Birmaher B,Ryan ND,Wiliamson DE,et al.Childhood and adolescent depression:A review of the past 10 years.Part 1[J].J Am Adcd Child Adolesc Psychiatry,1996,35(1):1427-1439.
4Alderman J, Wolkow R, Chung M, et al. Sertraline treatment of children and adolescents with obsessive compulsive disorder or depression: pharmacokinetics, tolerability, and efficacy[J].J Am Acad Psychiatry, 1998,37(4): 386.
5Wolkow R, March J, Biederman J, et al. Sertraline in pediatric obsessive compulsive disorder: a multicenter controlled trial[J].J Clin Psy,1997,41(2):324.
6Leonard HL, March J, Rickler KC, et al. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents[J].J Am Acad Child Adolesc Psychiatry,1997,36(6):725.
7Lynch A, Glod CA, Fitzgerald F. Psychopharmacologic treatment of adolescent depression[J].Arch Psychiatry Nurs,2001, 15(1):41-47.
8Findling RL, Reed MD, Blumer JL. Pharmacological treatment of depression in children and adolescents[J].Paediatr Drugs, 1999,1(3):161-182.
9Fleming JE, Offord DR Bovle MH. Preavlence of childhood and adolescent depression the community. Ontario chil heal stud Br J Psych, 1989, 155:647 - 654.
10Brent DA, Binnaher B. Kolko, et al. Depression. NEJM, 2002,347 : 667 -671.
7Nobile M,Cataldo MG,Giorda R,et al. A case-control and family-based association study of the 5-HTTLPR in pediatrlc-onset depressive disorders[J]. Biol Psychiatry,2004,56(4):292-295.
